TORNTPHARM 5200 PE (PUT) 23 November 2026 options price chart analysis Torrent Pharmaceuticals Limited

TORNTPHARM 5200 PE is trading at ₹ on 8:03pm 05 Thu Nov 2026

10 minute average: ₹ 0
30 minute average: ₹ 0
Hourly average: ₹ 0
Day open: ₹
Day range: -
Open Interest: (0 K)

Munafa Value: 50 - This score indicates that the option of TORNTPHARM 5200 PE does not have a definite trend. You can choose to wait till it shows a definite trend, or avoid it completely.

Lot size of TORNTPHARM is: 125

Spot price of TORNTPHARM: 4710.000 as on 05 Thu Nov 3:45pm
Day open: 4753.400 Range: 4679.100 to 4753.400

Option Price: TORNTPHARM PE 5200 2026-11-23 on 05 Thu Nov 2026

Time

Option Price

Open Interest

Open

High

Low

option chart TORNTPHARM PE 5200 2026-11-23

White line on the chart is the option premium, and gray line just under it is the open interest. Candle stick charts use day open, day high, day low, and current LTP of the premium. Please note that high low shadows are only plotted when a new high or low is made, otherwise, only candle body is plotted.

What is premium price of TORNTPHARM 5200 PE PUT today?: Premium of TORNTPHARM 5200 PE is 481.35 on 05 Nov 2026 PUT opened at 481.35 and traded inside a Low-High range of 481.35-481.35 today. Please click here table for more current prices.
What is open interest of TORNTPHARM 5200 PUT PE today?: Open Interest of TORNTPHARM 5200 PE is 375 today. This has changed 375.00 from previous day.
What is underlying price of TORNTPHARM 5200 PE PUT today?: Underlying price of TORNTPHARM 5200 PE PUT is 4710.01 today.
What is lot size of TORNTPHARM 5200 PUT PE today?: Lot size of TORNTPHARM 5200 PUT PE is 125.00
Is TORNTPHARM 5200 PE PUT ITM or OTM or ATM?: TORNTPHARM 5200 PUT PE is ITM PUT option (in the money). Only ITM options have intrinsic value in them, while OTM options have only time value in them.

Live Options price premium & chart analysis for TORNTPHARM 5200 PE (PUT) 23 November 2026 options price chart analysis Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited TORNTPHARM trades in NSE under Pharmaceuticals NSE

Underlying equity prev closing: 4710.00

TORNTPHARM PUT PE available options strikes

TORNTPHARM PE 4500 strike, TORNTPHARM PE 4550 strike, TORNTPHARM PE 4600 strike, TORNTPHARM PE 4650 strike, TORNTPHARM PE 4700 strike, TORNTPHARM PE 4750 strike, TORNTPHARM PE 4800 strike, TORNTPHARM PE 4850 strike, TORNTPHARM PE 4900 strike, All CE , All PE

TORNTPHARM 5200 PUT PE available expiry dates

TORNTPHARM 23 Nov 2026 expiry TORNTPHARM 29 Dec 2026 expiry TORNTPHARM 25 Jan 2027 expiry

TORNTPHARM 5200 PE Live prices

Premium of PUT (PE) of strike 5200 is at: 481.35 on 05 Nov 2026
PUT opened at 481.35 and traded inside a Low-High range of 481.35-481.35 as on 05 Thu Nov 2026

The underlying equity is trading at 4710.00 which means that PUT of strike 5200 is ITM PUT option (in the money)

Lot size of TORNTPHARM Torrent Pharmaceuticals Limited is 125

Total Open Interest for PUT (PE) of strike 5200 is 375

Price action analysis of 5200 PUT based on a short term time period is neutral. A longer time frame might give a better analysis.

Click here to view most profitable CE and PE for Torrent Pharmaceuticals Limited, both for buyers and sellers | TORNTPHARM Most Active Call Put Options

Date	Underlying price	PE price	PE open	PE high	PE low	PE volume	PE OI	OI Change
05 Thu Nov	4710.00	481.35	481.35	481.35	481.35	27	46,875	-%
30 Fri Oct	4650.00	376.55	0.00	0.00	0.00	0	0	-%
29 Thu Oct	4595.00	376.55	0.00	0.00	0.00	0	0	-%
28 Wed Oct	4613.40	376.55	0.00	0.00	0.00	0	0	-%
27 Tue Oct	4580.00	376.55	0.00	0.00	0.00	0	0	-%
26 Mon Oct	4557.00	376.55	0.00	0.00	0.00	0	0	-%

Charts for TORNTPHARM 5200 PUT PE options for Torrent Pharmaceuticals Limited

Select an expiry and a strike price below to view charts for those options. TORNTPHARM All in One charts

Charts for:

Dark shadowed line on the chart below is the current SPOT price line of underlying equity. White line on the chart is the option closing price line. Candle sticks on the chart are the OHLC for the option.

TORNTPHARM further analysis